29 October 2024NewsAmericasWendy Devine, Partner, Wilson Sonsini | Jesse Fecker, Vice President, Head of IP, Theravance Bio | Christina Susanto, Director of IP, Sutro Bipharma | Lawrence Kong, Executive Director, Legal and Intellectual Property, Addition Therapeutics

WATCH: Aligning innovation, regulation and IP protection

Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

UK court clears the way for Amgen and Samsung to launch biosimilars

SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute

‘It’s going to be very different’: INTA CEO shares London meeting plans

'Scrap the billable hour': LSIPR joins INTA panel on gender diversity

Sanofi unit loses genetic disorder patent at EPO after trio of challenges

INTA confirms London as host city for Annual Meeting 2026

INTA unveils key principles on AI and IP rights at Annual Meeting

Illumina takes aim at rival in gene sequencing spat

WATCH: Aligning innovation, regulation and IP protection

Editor's picks

Editor's picks

More features